This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lathion, S. Articles by Raj, K. Search for Related Content PubMed PubMed Citation Articles by Lathion, S. Articles by Raj, K.

Notch1 Can Contribute to Viral-Induced Transformation of Primary Human Keratinocytes

Swiss Institute for Experimental Cancer Research (ISREC) and National Center of Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland

The human papillomavirus (HPV) is the most significant causative agent in the development of cervical cancer. Despite its presence in almost all cervical cancers, HPV by itself is unable to transform a normal cell to a cancerous one. Instead, additional cellular mutations are required to supplement the HPV oncoproteins E6 and E7. Activation of the Notch1 signaling pathway has been proposed as one of the cellular changes that cooperate with the E6 and E7 proteins to cause cervical cancers. This proposition is based on: (a) the detection of active Notch1 in high-grade cervical lesions and cancers; (b) the synergism between Notch1 and E6 and E7 to transform immortalized cells; and (c) the obliteration of neoplastic properties of a cervical cancer cell line when Notch1 expression was inhibited. However, this view was put in doubt by a recent report that showed Notch1 expression is markedly reduced in cervical cancer cells, and this was attributed to the ability of Notch1 to repress the expression of the HPV E6 and E7 proteins. Here we report that although exaggerated levels of Notch1 can, indeed, adversely affect HPV E6 and E7 expression, and cellular proliferation in general, moderate levels of Notch1, together with active phosphoinositide 3 kinase, can, instead, exhibit oncogenic properties that transform primary cells containing HPV16 E6 and E7 proteins. In addition, we show that activated Notch1 is readily detected in all cervical cancer cell lines tested. Together, these results show that not only do cervical cancer cells express Notch1, but also that Notch1 signaling, in synergy with other cellular changes, can participate in the transformation of primary cells expressing E6 and E7 proteins.

This article has been cited by other articles:

				T. Yugawa, K. Handa, M. Narisawa-Saito, S.-i. Ohno, M. Fujita, and T. Kiyono Regulation of Notch1 Gene Expression by p53 in Epithelial Cells Mol. Cell. Biol., May 15, 2007; 27(10): 3732 - 3742. [Abstract] [Full Text] [PDF]

				Y. Zhao, R. B. Katzman, L. M. Delmolino, I. Bhat, Y. Zhang, C. B. Gurumurthy, A. Germaniuk-Kurowska, H. V. Reddi, A. Solomon, M.-S. Zeng, et al. The Notch Regulator MAML1 Interacts with p53 and Functions as a Coactivator J. Biol. Chem., April 20, 2007; 282(16): 11969 - 11981. [Abstract] [Full Text] [PDF]

				L. Miele Notch Signaling Clin. Cancer Res., February 15, 2006; 12(4): 1074 - 1079. [Full Text] [PDF]

				K. Veeraraghavalu, V. K. Subbaiah, S. Srivastava, O. Chakrabarti, R. Syal, and S. Krishna Complementation of Human Papillomavirus Type 16 E6 and E7 by Jagged1-Specific Notch1-Phosphatidylinositol 3-Kinase Signaling Involves Pleiotropic Oncogenic Functions Independent of CBF1;Su(H);Lag-1 Activation J. Virol., June 15, 2005; 79(12): 7889 - 7898. [Abstract] [Full Text] [PDF]

				K. Veeraraghavalu, M. Pett, R. V. Kumar, P. Nair, A. Rangarajan, M. A. Stanley, and S. Krishna Papillomavirus-Mediated Neoplastic Progression Is Associated with Reciprocal Changes in Jagged1 and Manic Fringe Expression Linked to Notch Activation J. Virol., August 15, 2004; 78(16): 8687 - 8700. [Abstract] [Full Text] [PDF]

				O. Chakrabarti, K. Veeraraghavalu, V. Tergaonkar, Y. Liu, E. J. Androphy, M. A. Stanley, and S. Krishna Human Papillomavirus Type 16 E6 Amino Acid 83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate Tumorigenesis by Notch Signaling and Oncogenic Ras J. Virol., June 1, 2004; 78(11): 5934 - 5945. [Abstract] [Full Text] [PDF]